EXPLORATORY GRANTS IN CANCER CONTROL (R21 CLINICAL TRIAL OPTIONAL)
The costs for the two-year project cannot exceed $275,000 - June 16, 2028
National Institutes of Health (NIH)-R21 Exploratory/Developmental Research Grant*NCI R21 grants fund factors early-stage, innovative research on cancer control, including behavior, screening, and risk, to advance population-based cancer.
